Loading
NASDAQHealthcareMedical - Healthcare Information Services
Latest quote
$0.411
+$0.0207 · +5.30%
Mangoceuticals, Inc. dedicates its operations to the creation, promotion, and distribution of a variety of health and wellness products and services specifically designed for men. These offerings are primarily delivered through a telemedicine platform. The company's product line includes treatments for erectile dysfunction, marketed under the 'Mango' brand. Consumers can purchase these items directly from its official online portal, mangorx.com. Established in 2021, Mangoceuticals, Inc. is headquartered in Dallas, Texas, and operates as an affiliate of Cohen Enterprises, Inc.
Previous close
$0.411
+$0.0207 · +5.30%
Pre-market
$0.4003
−$0.0107 · -2.60%
Sep 8, 8:08 AM ET
Regular session · ET · Market data may be delayed.
Mangoceuticals, Inc. dedicates its operations to the creation, promotion, and distribution of a variety of health and wellness products and services specifically designed for men. These offerings are primarily delivered through a telemedicine platform. The company's product line includes treatments for erectile dysfunction, marketed under the 'Mango' brand. Consumers can purchase these items directly from its official online portal, mangorx.com. Established in 2021, Mangoceuticals, Inc. is headquartered in Dallas, Texas, and operates as an affiliate of Cohen Enterprises, Inc.
Day range
Current $0.411
52-week range
Current $0.411
Regular session · ET · Market data may be delayed.
GoAI Score
Sell
Valuation
35
Expensive
Sentiment
51
Mixed
Risk
83
Extreme Risk
Momentum
23
Weakening
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
Mangoceuticals, Inc. dedicates its operations to the creation, promotion, and distribution of a variety of health and wellness products and services specifically designed for men. These offerings are primarily delivered through a telemedicine platform. The company's product line includes treatments for erectile dysfunction, marketed under the 'Mango' brand. Consumers can purchase these items directly from its official online portal, mangorx.com. Established in 2021, Mangoceuticals, Inc. is headquartered in Dallas, Texas, and operates as an affiliate of Cohen Enterprises, Inc.
Day range
Current $0.411
52-week range
Current $0.411
Profitability as a percentage of reported revenue.
Revenue
Operating income
Net income
| Metric (USD) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 456.02K USD | 615.87K USD | 731.49K USD | 8.94K USD | — |
| Cost of goods sold | 205.64K USD | 235.91K USD | 299.99K USD | 4.09K USD | — |
| Gross profit | 250.39K USD | 379.96K USD | 431.5K USD | 4.85K USD | — |
| Selling, general, and administrative | 16.72M USD | 7.9M USD | 5.42M USD | 2M USD | 17.52K USD |
| Operating expenses | 19.41M USD | 8.35M USD | 9.65M USD | 2M USD | 17.52K USD |
| Interest income | — | — | 6.47K USD | — | — |
| Interest expense | 103.51K USD | 13.7K USD | — | 6.47K USD | 181 USD |
| Depreciation and amortization | 1.72M USD | 721.53K USD | 24.89K USD | 3.86K USD | — |
| Operating income | −19.15M USD | −7.97M USD | −9.22M USD | −1.99M USD | −17.52K USD |
| Net income | −20.64M USD | −8.71M USD | −9.21M USD | −2M USD | −17.7K USD |
Company facts updated Sep 8, 2026.
Recent quarterly results
Recent quarterly results
Funds reporting this stock among their holdings, ordered by reported position size.
AI-generated and delayed market data for informational and educational purposes only. Not investment advice.
